COVID-19 Impact on Global Osteoporosis Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: CB25810CFB34EN
QYResearch

Abstracts

This report focuses on the global Osteoporosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteoporosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan Plc
• Amgen, Inc.
• Actavis Plc.
• Eli Lilly and Company
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Pharmaceutical Ltd.
• Merck & Co AG
• Novartis AG
• Novo Nordisk A/S
• Pfizer, Inc.
• Teva Pharmaceuticals Industries Ltd.

Market segment by Type, the product can be split into

• Bisphosphonates
• Parathyroid Hormone Therapy
• Calcitonin
• Selective Estrogen Inhibitors Modulator (SERM)

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Osteoporosis Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Osteoporosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Osteoporosis Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteoporosis Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Osteoporosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Bisphosphonates
  1.4.3 Parathyroid Hormone Therapy
  1.4.4 Calcitonin
  1.4.5 Selective Estrogen Inhibitors Modulator (SERM)
1.5 Market by Application
  1.5.1 Global Osteoporosis Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Osteoporosis Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Osteoporosis Treatment Industry
    1.6.1.1 Osteoporosis Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Osteoporosis Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Osteoporosis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Osteoporosis Treatment Market Perspective (2015-2026)
2.2 Osteoporosis Treatment Growth Trends by Regions
  2.2.1 Osteoporosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Osteoporosis Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Osteoporosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Osteoporosis Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Osteoporosis Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Osteoporosis Treatment Players by Market Size
  3.1.1 Global Top Osteoporosis Treatment Players by Revenue (2015-2020)
  3.1.2 Global Osteoporosis Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Osteoporosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteoporosis Treatment Market Concentration Ratio
  3.2.1 Global Osteoporosis Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Osteoporosis Treatment Revenue in 2019
3.3 Osteoporosis Treatment Key Players Head office and Area Served
3.4 Key Players Osteoporosis Treatment Product Solution and Service
3.5 Date of Enter into Osteoporosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Osteoporosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Osteoporosis Treatment Forecasted Market Size by Type (2021-2026)

5 OSTEOPOROSIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Osteoporosis Treatment Market Size by Application (2015-2020)
5.2 Global Osteoporosis Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Osteoporosis Treatment Market Size (2015-2020)
6.2 Osteoporosis Treatment Key Players in North America (2019-2020)
6.3 North America Osteoporosis Treatment Market Size by Type (2015-2020)
6.4 North America Osteoporosis Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Osteoporosis Treatment Market Size (2015-2020)
7.2 Osteoporosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Osteoporosis Treatment Market Size by Type (2015-2020)
7.4 Europe Osteoporosis Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Osteoporosis Treatment Market Size (2015-2020)
8.2 Osteoporosis Treatment Key Players in China (2019-2020)
8.3 China Osteoporosis Treatment Market Size by Type (2015-2020)
8.4 China Osteoporosis Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Osteoporosis Treatment Market Size (2015-2020)
9.2 Osteoporosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Osteoporosis Treatment Market Size by Type (2015-2020)
9.4 Japan Osteoporosis Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Osteoporosis Treatment Market Size (2015-2020)
10.2 Osteoporosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteoporosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Osteoporosis Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Osteoporosis Treatment Market Size (2015-2020)
11.2 Osteoporosis Treatment Key Players in India (2019-2020)
11.3 India Osteoporosis Treatment Market Size by Type (2015-2020)
11.4 India Osteoporosis Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Osteoporosis Treatment Market Size (2015-2020)
12.2 Osteoporosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteoporosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Osteoporosis Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Allergan Plc
  13.1.1 Allergan Plc Company Details
  13.1.2 Allergan Plc Business Overview and Its Total Revenue
  13.1.3 Allergan Plc Osteoporosis Treatment Introduction
  13.1.4 Allergan Plc Revenue in Osteoporosis Treatment Business (2015-2020))
  13.1.5 Allergan Plc Recent Development
13.2 Amgen, Inc.
  13.2.1 Amgen, Inc. Company Details
  13.2.2 Amgen, Inc. Business Overview and Its Total Revenue
  13.2.3 Amgen, Inc. Osteoporosis Treatment Introduction
  13.2.4 Amgen, Inc. Revenue in Osteoporosis Treatment Business (2015-2020)
  13.2.5 Amgen, Inc. Recent Development
13.3 Actavis Plc.
  13.3.1 Actavis Plc. Company Details
  13.3.2 Actavis Plc. Business Overview and Its Total Revenue
  13.3.3 Actavis Plc. Osteoporosis Treatment Introduction
  13.3.4 Actavis Plc. Revenue in Osteoporosis Treatment Business (2015-2020)
  13.3.5 Actavis Plc. Recent Development
13.4 Eli Lilly and Company
  13.4.1 Eli Lilly and Company Company Details
  13.4.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.4.3 Eli Lilly and Company Osteoporosis Treatment Introduction
  13.4.4 Eli Lilly and Company Revenue in Osteoporosis Treatment Business (2015-2020)
  13.4.5 Eli Lilly and Company Recent Development
13.5 F. Hoffmann La Roche Ltd.
  13.5.1 F. Hoffmann La Roche Ltd. Company Details
  13.5.2 F. Hoffmann La Roche Ltd. Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann La Roche Ltd. Osteoporosis Treatment Introduction
  13.5.4 F. Hoffmann La Roche Ltd. Revenue in Osteoporosis Treatment Business (2015-2020)
  13.5.5 F. Hoffmann La Roche Ltd. Recent Development
13.6 GlaxoSmithKline Pharmaceutical Ltd.
  13.6.1 GlaxoSmithKline Pharmaceutical Ltd. Company Details
  13.6.2 GlaxoSmithKline Pharmaceutical Ltd. Business Overview and Its Total Revenue
  13.6.3 GlaxoSmithKline Pharmaceutical Ltd. Osteoporosis Treatment Introduction
  13.6.4 GlaxoSmithKline Pharmaceutical Ltd. Revenue in Osteoporosis Treatment Business (2015-2020)
  13.6.5 GlaxoSmithKline Pharmaceutical Ltd. Recent Development
13.7 Merck & Co AG
  13.7.1 Merck & Co AG Company Details
  13.7.2 Merck & Co AG Business Overview and Its Total Revenue
  13.7.3 Merck & Co AG Osteoporosis Treatment Introduction
  13.7.4 Merck & Co AG Revenue in Osteoporosis Treatment Business (2015-2020)
  13.7.5 Merck & Co AG Recent Development
13.8 Novartis AG
  13.8.1 Novartis AG Company Details
  13.8.2 Novartis AG Business Overview and Its Total Revenue
  13.8.3 Novartis AG Osteoporosis Treatment Introduction
  13.8.4 Novartis AG Revenue in Osteoporosis Treatment Business (2015-2020)
  13.8.5 Novartis AG Recent Development
13.9 Novo Nordisk A/S
  13.9.1 Novo Nordisk A/S Company Details
  13.9.2 Novo Nordisk A/S Business Overview and Its Total Revenue
  13.9.3 Novo Nordisk A/S Osteoporosis Treatment Introduction
  13.9.4 Novo Nordisk A/S Revenue in Osteoporosis Treatment Business (2015-2020)
  13.9.5 Novo Nordisk A/S Recent Development
13.10 Pfizer, Inc.
  13.10.1 Pfizer, Inc. Company Details
  13.10.2 Pfizer, Inc. Business Overview and Its Total Revenue
  13.10.3 Pfizer, Inc. Osteoporosis Treatment Introduction
  13.10.4 Pfizer, Inc. Revenue in Osteoporosis Treatment Business (2015-2020)
  13.10.5 Pfizer, Inc. Recent Development
13.11 Teva Pharmaceuticals Industries Ltd.
  10.11.1 Teva Pharmaceuticals Industries Ltd. Company Details
  10.11.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
  10.11.3 Teva Pharmaceuticals Industries Ltd. Osteoporosis Treatment Introduction
  10.11.4 Teva Pharmaceuticals Industries Ltd. Revenue in Osteoporosis Treatment Business (2015-2020)
  10.11.5 Teva Pharmaceuticals Industries Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Osteoporosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Osteoporosis Treatment Revenue
Table 3. Ranking of Global Top Osteoporosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteoporosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Parathyroid Hormone Therapy
Table 7. Key Players of Calcitonin
Table 8. Key Players of Selective Estrogen Inhibitors Modulator (SERM)
Table 9. COVID-19 Impact Global Market: (Four Osteoporosis Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Osteoporosis Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Osteoporosis Treatment Players to Combat Covid-19 Impact
Table 14. Global Osteoporosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Osteoporosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Osteoporosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Osteoporosis Treatment Market Share by Regions (2015-2020)
Table 18. Global Osteoporosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Osteoporosis Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Osteoporosis Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Osteoporosis Treatment Players
Table 25. Global Osteoporosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Osteoporosis Treatment Market Share by Players (2015-2020)
Table 27. Global Top Osteoporosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Treatment as of 2019)
Table 28. Global Osteoporosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Osteoporosis Treatment Product Solution and Service
Table 31. Date of Enter into Osteoporosis Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Osteoporosis Treatment Market Size Share by Type (2015-2020)
Table 35. Global Osteoporosis Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Osteoporosis Treatment Market Size Share by Application (2015-2020)
Table 37. Global Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Osteoporosis Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 41. North America Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Osteoporosis Treatment Market Share by Type (2015-2020)
Table 43. North America Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Osteoporosis Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 47. Europe Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Osteoporosis Treatment Market Share by Type (2015-2020)
Table 49. Europe Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Osteoporosis Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 53. China Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Osteoporosis Treatment Market Share by Type (2015-2020)
Table 55. China Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Osteoporosis Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 59. Japan Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Osteoporosis Treatment Market Share by Type (2015-2020)
Table 61. Japan Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Osteoporosis Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 65. Southeast Asia Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Osteoporosis Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Osteoporosis Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 71. India Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Osteoporosis Treatment Market Share by Type (2015-2020)
Table 73. India Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Osteoporosis Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Osteoporosis Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Osteoporosis Treatment Market Share (2019-2020)
Table 77. Central & South America Osteoporosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Osteoporosis Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Osteoporosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Osteoporosis Treatment Market Share by Application (2015-2020)
Table 81. Allergan Plc Company Details
Table 82. Allergan Plc Business Overview
Table 83. Allergan Plc Product
Table 84. Allergan Plc Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 85. Allergan Plc Recent Development
Table 86. Amgen, Inc. Company Details
Table 87. Amgen, Inc. Business Overview
Table 88. Amgen, Inc. Product
Table 89. Amgen, Inc. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 90. Amgen, Inc. Recent Development
Table 91. Actavis Plc. Company Details
Table 92. Actavis Plc. Business Overview
Table 93. Actavis Plc. Product
Table 94. Actavis Plc. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 95. Actavis Plc. Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Product
Table 99. Eli Lilly and Company Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 100. Eli Lilly and Company Recent Development
Table 101. F. Hoffmann La Roche Ltd. Company Details
Table 102. F. Hoffmann La Roche Ltd. Business Overview
Table 103. F. Hoffmann La Roche Ltd. Product
Table 104. F. Hoffmann La Roche Ltd. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 105. F. Hoffmann La Roche Ltd. Recent Development
Table 106. GlaxoSmithKline Pharmaceutical Ltd. Company Details
Table 107. GlaxoSmithKline Pharmaceutical Ltd. Business Overview
Table 108. GlaxoSmithKline Pharmaceutical Ltd. Product
Table 109. GlaxoSmithKline Pharmaceutical Ltd. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 110. GlaxoSmithKline Pharmaceutical Ltd. Recent Development
Table 111. Merck & Co AG Company Details
Table 112. Merck & Co AG Business Overview
Table 113. Merck & Co AG Product
Table 114. Merck & Co AG Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 115. Merck & Co AG Recent Development
Table 116. Novartis AG Business Overview
Table 117. Novartis AG Product
Table 118. Novartis AG Company Details
Table 119. Novartis AG Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 120. Novartis AG Recent Development
Table 121. Novo Nordisk A/S Company Details
Table 122. Novo Nordisk A/S Business Overview
Table 123. Novo Nordisk A/S Product
Table 124. Novo Nordisk A/S Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 125. Novo Nordisk A/S Recent Development
Table 126. Pfizer, Inc. Company Details
Table 127. Pfizer, Inc. Business Overview
Table 128. Pfizer, Inc. Product
Table 129. Pfizer, Inc. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 130. Pfizer, Inc. Recent Development
Table 131. Teva Pharmaceuticals Industries Ltd. Company Details
Table 132. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 133. Teva Pharmaceuticals Industries Ltd. Product
Table 134. Teva Pharmaceuticals Industries Ltd. Revenue in Osteoporosis Treatment Business (2015-2020) (Million US$)
Table 135. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Osteoporosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Bisphosphonates Features
Figure 3. Parathyroid Hormone Therapy Features
Figure 4. Calcitonin Features
Figure 5. Selective Estrogen Inhibitors Modulator (SERM) Features
Figure 6. Global Osteoporosis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Osteoporosis Treatment Report Years Considered
Figure 11. Global Osteoporosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Osteoporosis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Osteoporosis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Osteoporosis Treatment Market Share by Players in 2019
Figure 16. Global Top Osteoporosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Osteoporosis Treatment Revenue in 2019
Figure 18. North America Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Osteoporosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Plc Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 27. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen, Inc. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 29. Actavis Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Actavis Plc. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 31. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Eli Lilly and Company Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 33. F. Hoffmann La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. F. Hoffmann La Roche Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 35. GlaxoSmithKline Pharmaceutical Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GlaxoSmithKline Pharmaceutical Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 37. Merck & Co AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Merck & Co AG Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 39. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Novartis AG Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 41. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Novo Nordisk A/S Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 43. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Pfizer, Inc. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 45. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Osteoporosis Treatment Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed